2008 Facts and Figures

8/8/2019 2008 Facts and Figures

1/20

Carl Zeiss in Focus


2/20

Facts and figures


3/20

1.3 Carl Zeiss in Focus 2008

Carl Zeiss is a leading group of companies in the optical and

opto-electronic industry.

Carl Zeiss AG is the core of the Carl Zeiss Group.

The company is not publicly listed and is wholly owned by the

Carl Zeiss Foundation.

Carl Zeiss focuses on the future-oriented markets of

Medical Research Solutions

Industrial Solutions and Lifestyle Products

Life sciences, nanotechnology, medical technology, automation

and software solutions these are the subjects of the future.

Carl Zeiss is at home in these promising sectors.

Carl Zeiss A Unique Enterprise


4/20

"Since pioneering science in optics, we continue to challenge

the limits of mans imagination. With our passion for excellence,

we create value for our customers and inspire the world in new

ways.

Our Vision

The mission statement of our corporate vision forms the basis of

our aspiration:

We make it visible.



5/20

7 percent increase in revenue to EUR 2,604 million

Growth in incoming business by 7 percent to a volume of EUR 2,704 million

Consolidated net income increased by 40 percent to EUR 233 million

EVA increase in corporate value of EUR 133 million

Further improvement in all major balance sheet items

Fiscal Year 2006/07 Completed with Record Figures


(Balance sheet date: September 30, 2007)


6/20

(Carl Zeiss SMT AG)

Lithography

Systems

Process Control

Systems

(Carl Zeiss Industrielle

Messtechnik GmbH)

3D Metrology

(Carl Zeiss MicroImaging GmbH)

Light Microscopy

Laser Scanningmicroscopy

(Carl Zeiss Meditec AG)

Solutions for

Ophthalmology

(Carl Zeiss Surgical GmbH)

Surgical Products

(Carl Zeiss Vision

International GmbH)

Valued at equity

in consolidated

operating result

Eyeglass lenses

(Carl Zeiss Optronics GmbH)

Optronics

(Carl Zeiss AG)

Still and CineCamera Lenses

(Carl Zeiss Jena GmbH)

Planetariums

(Carl Zeiss Sports Optics GmbH)

Binoculars, SpottingScopes, Riflescopes

Carl Zeiss Vision

(Joint venture)

SemiconductorTechnology

IndustrialMetrology

MicroscopyMedical SystemsConsumer Optics/

Optronics

Medical and ResearchSolutions

IndustrialSolutions

LifestyleProducts

Carl Zeiss Continues Dynamic GrowthRevenue in Fiscal Year 2006/07 Increased to EUR 2,604 Million

Markets

EUR 638m EUR 323m EUR 245mEUR 316mEUR 1,042m EUR 844m

Sales Revenues

1.6 Carl Zeiss im Fokus 2008


7/20

Total employees(Sept. 30, 2007)

Revenue in EUR bn

Trends in Revenues and Number of Employees


2002/03* 2003/04* 2004/05 2005/06 2006/07

* incl. employees in Eyeglass Division

HGB IFRS

2.222.142.03

14,151 13,667

11,049 11,249 12,257

2.602.43


8/20

Financial highlights

2006/07 2005/06

Sales revenues 2,604 2,433

EBITDA 540 437

Depreciation 114 118

EBIT 394 313

Equity ratio 33% 22%

Cash flow before taxes 549 410

EVA(Economic Value Added) 133 82

Figures in EUR million


Earnings before taxes 375 256

Income taxes -142 -89

Consolidated net income 233 167


9/20

66%

2%

20%12%

17%

Revenue Distribution by Region


Asia

EUR 315 million+ 7 %*Americas

EUR 530 million

0 %*Others

EUR 41 million+ 15 %

Rest of Europe

EUR 1,718 million+ 13 %

Germany

EUR 432 million

+ 14 %

* Adjusted for currency influences at previous year's exchange rates


10/20

Carl Zeiss will be regarded as the most

innovative company in its fields of

business.From the Corporate Vision

Innovation the Foundation of Success

With innovative products and services,

we offer our customers solutions that

help them to be successful.

Approx. 16 percent of our employees

work in research and development.



11/20

Employees in R&D worldwide

(Sept. 30, 2007)

**in % of total employees

R&D expenditure in EUR million

*Percentage of total revenue

Sustained Investment in Research and Development


2002/03 2003/04 2004/05 2005/06 2006/07

254

230

209190

1,669

12% 1,55312%

1,605

14%

1,750

16%

1,935

16%**

290

9%*10%*

10%*

10%*

11%*


12/20

Carl Zeiss generates almost 60 percent of itsrevenues with products not older than five years


344371

399368

384

2002/03 2003/04 2004/05 2005/06 2006/07

Patent applications

About two patents every workday:

efficient structures in the innovation process ensure ongoing success


13/20

The demographic trend in the industrialized

world resulting from growing life expectancy

and rising living standards in emergingeconomies is leading to an increasing

demand for medical technology solutions.

The life sciences are playing an important

role in this development: innovativemicroscope systems support the tissue-

based diagnosis of diseases and the

selection of the appropriate therapy.

With a wide range of products, Carl Zeiss

helps to preserve and improve vision, our

most important sense of perception.

Future Growth MarketsMedical and Research Solutions



14/20

Nanotechnology, digitization, automation

these are the subjects that will define

industrial development, now and in thefuture.

Powerful microchips are the basis for

providing and processing information at an

ever-faster pace. Innovative optics from CarlZeiss are the key to the microchip

generations of tomorrow.

Products and solutions for measuring and

analysis technology are helping to expertly

master highly complex processes in the

micrometer and nanometer ranges.

Future Growth MarketsIndustrial Solutions



15/20

Innovative technology from Carl Zeiss is

incorporated in many things that make life

more enjoyable and interesting:in camera phones with outstanding lenses

for capturing those perfect moments, in

high-grade digital cameras for recording

memories of a wonderful vacation or in

binoculars for rediscovering the world ofnature.

The economic development in many

countries permits an increasing number of

people to purchase high-quality consumer

goods that promise new experiences.

Future Growth MarketsLifestyle Products



16/20

Executive Board of Carl Zeiss AG

Dieter Kurz, Dr. rer. nat (CEO) (center)

(Physicist) President and CEO, Labor Director, Member of the Board

responsible for Industrial Measuring Technology, Consumer Optics,Optronics, Strategic Corporate Development, Corporate Research and

Technology, Corporate Communications, Corporate Human

Resources, Corporate Auditing, Risk Management and Legal Affairs

and Patents

Hermann Gerlinger, Dr. rer. nat (left)

(Physicist), Member of the Board responsible for Semiconductor

Technology, Quality and Processes, Opto-electronic Systems and the

Service Centers, as well as President and CEO of Carl Zeiss SMT AG

Michael Kaschke, Dr. sc. nat (CFO)(right)

(Physicist), Member of the Board responsible for Microscopy, Medical

Systems, Corporate Finance, Controlling and Taxes, and Corporate IT



17/20

Carl Zeiss GroupProduction Plants and Sales Organizations

Europe

7 production sites

in 5 countries25 sales locations

in 18 countries

Americas

4 production sites

in 2 countries6 sales locations

in 4 countries

Asia

2 production sites

in 1 country10 sales locations

in 9 countries

Africa

1 production site

1 sales location



18/20

Carl Zeiss A Tradition of Success

1846/ Founding of the company by Carl Zeiss (18161888)

1875 The outstanding scientist and entrepreneur Ernst Abbe(18401905) becomes Zeiss' partner in the business

1889 Abbe creates the Carl Zeiss Foundation to which all interests in

the companies Carl Zeiss and Schott Glassworks are

subsequently transferred to ensure that their future is notdependent on individual persons

1945 Partition of the company into two parts as a result of World War II

1990 The merger of the two Carl Zeiss companies begins after the

reunification of Germany



19/20

Carl Zeiss A Tradition of Success

2001 The Semiconductor Technology Group becomes a stock

corporation (wholly owned by Carl Zeiss)

2004 Carl Zeiss is transformed into a stock corporation (wholly ownedby the Carl Zeiss Foundation)

2002 The Ophthalmology Division merges with Asclepion-Meditec AG

to form the listed company Carl Zeiss Meditec AG (Carl Zeiss

share


20/20

Documents

2008 Facts and Figures